Navigation Links
Common cholesterol drug safe, may improve learning disabilities in patients with neurofibromatosis
Date:9/27/2011

he world to perform a definitive study to replicate these findings on a larger scale."

This Phase I study looked at the safety and efficacy of lovastatin as a treatment for patients with neurofibromatosis type 1, which accounts for the majority of NF cases. Over a period of three months, 24 patients between ages 10-17 years received treatment with lovastatin. Patients were given cognitive functioning tests before and after treatment. All patients maintained normal cholesterol levels throughout the study, and there were some cognitive improvements in memory, visual attention, and efficiency following treatment.

"The implications for all children with learning disabilities not only those with NF1 are of interest to the greater pediatric community, so we hope to move forward quickly through the Consortium to advance this research in NF1 patients in a timely manner," commented Roger Packer, MD, Senior Vice President of the Center for Neuroscience and Behavioral Medicine, Director of the Gilbert Family Neurofibromatosis Institute at Children's National, and Group Chair of the Department of Defense Neurofibromatosis Clinical Trials Consortium.


'/>"/>

Contact: Emily Hartman
ehartman@childrensnational.org
202-476-4500
Children's National Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Study provides insight on a common heart rhythm disorder
2. Researchers identify Achilles heel of common childhood tumor
3. First comprehensive genomic study of common cold reveals new treatment targets
4. GUMC researchers hone in on new strategy to treat common infection
5. Hairspray is linked to common genital birth defect, says study
6. Common food additive found to increase risk and speed spread of lung cancer
7. Mayo Clinic: Brain disorder suggests common mechanism may underlie many neurodegenerative diseases
8. Scientists uncover evolutionary keys to common birth disorders
9. Common soil mineral degrades the nearly indestructible prion
10. Genetic testing not cost-effective in guiding initial dosing of common blood thinner
11. New vaccine developed for preventing uncommon cold virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... natural habitats and trees and not just asphalt and ... a University of Colorado Boulder study. , Working on ... stress-reducing benefits for youth, according to a paper published ... study is one of the first of its kind ... green settings and stress. , "Many schools already offer ...
(Date:7/22/2014)... a child,s lunch box and you,re likely to find that ... Those are the findings of a study conducted by researchers ... Tufts University and in the Department of Public Health and ... findings are published online ahead of print in the ... , Led by senior author Jeanne Goldberg, Ph.D., R.D., a ...
(Date:7/22/2014)... 22, 2014 NXT-ID, Inc., (NXTD: OTCQB) a biometric ... announces its next generation smart wallet, Wocket™, will be featured ... show that airs on the History Channel, FYI ... regularly features top technology products and services. The ... History Channel (6:00-6:30am ET/PT) and the FYI Network ...
Breaking Biology News(10 mins):Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 2Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 3Room for improvement in elementary school children's lunches and snacks from home 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 3
... EUGENE, Ore.(Aug. 20, 2007)Nitric acid is a notoriously strong and ... our atmosphere. However, a team of researchers have found that ... top of a water surface. The discovery of the ... the surface of water requires us to re-evaluate how we ...
... of G&D, Drs. Maria Divina Deato and Robert Tjian ... alternative transcriptional core promoter complex directs cell-type specific differentiation ... of transcriptional control of terminal cell differentiation, and will ... date at www.genesdev.org . For nearly 30 ...
... after prior full-dose conventional radiation therapy respond to Boron ... a Phase I/II study at the Helsinki University Hospital, ... Heikki Joensuu, University of Helsinki, considers the results ... field for BNCT, since thus far BNCT has been ...
Cached Biology News:University of Oregon researcher finds that on water's surface, nitric acid is not so tough 2A new radiation therapy treatment developed for head and neck cancer patients 2
(Date:7/21/2014)... to a chain of carbon atoms can turn it ... Rice University scientists. , Stretching the material known as ... -- by just 3 percent can begin to change ... for mechanically activated nanoscale electronics and optics. , The ... colleagues appears in the American Chemical Society journal ...
(Date:7/21/2014)... ALBANY, New York , July 21, 2014 ... up-to-date research on Global & USA ... Market Size, Trends, and Forecasts ResearchMoz ... USA  Cancer Biomaker Market   to 2018 (Identification, Technologies, ... Strategies, Industry Trends, and Pipeline Analysis. ...
(Date:7/19/2014)... NewYork (PRWEB) July 20, 2014 ... , Summary , GlobalDatas new report, "United States ... market data on the United States Non-Vascular Stents ... US dollars, volume (in units) and average prices ... Stents (Plastic Biliary Stents and Metal Biliary Stents ...
(Date:7/18/2014)... The world is mostly neutral. That is, most ... The number of electrons in the outer parts ... centers of atoms. As one or more electrons ... feel a much stronger positive pull from the nucleus. ... in size, ensures that those electrons are less vulnerable ...
Breaking Biology Technology:Carbyne morphs when stretched 2Carbyne morphs when stretched 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4Highly charged ions 2Highly charged ions 3Highly charged ions 4
... MOUNT LAUREL, N.J. March 23 The ninth annual American ... the field of basic and clinical transplantation. This joint ... and the American Society of Transplantation ... at the John B. Hynes Convention Center in Boston, MA. ...
... Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today it ... million from Azimuth Opportunity Ltd. During the 18-month term of ... shares of its common stock to Azimuth Opportunity Ltd. at ... at its sole discretion, the timing and amount of any ...
... 23 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: ... report on Form 10-K for the year ended December ... CTI,s website at www.CellTherapeutics.com , or on the ... .As required under NASDAQ Marketplace Rule 4350(b)(1)(B), CTI also ...
Cached Biology Technology:American Transplant Congress 2009 2Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million 2
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Request Info...
Biology Products: